Canadian Drugmaker Apotex Files for an IPO in Toronto
THE SO WHAT
Apotex filing in Toronto instead of chasing a U.S. listing is a quiet data point that domestic capital markets can still support scaled generics. If you’re a healthcare operator in Canada, expect more pressure to stay local—on both financing and manufacturing footprint.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechTough World for Crypto ETFs: Roxanna Islam
Bitcoin dipping below $73,000 even as the CLARITY Act gets a presidential push says the trade is macro and flows, not Washington press releases. If your product depends on “pro-crypto” headlines to move capital, you’re misreading how institutional ETF buyers actually allocate risk.
Deep & Emerging TechWebsites are using this FROST-y new technique to spy on users by snooping on their SSD activity
Browser-based SSD side-channel attacks move “hardware exploitation” into the web stack — your threat model now includes drive behavior leaking through JavaScript. If you handle sensitive workloads in-browser, push for hardened configs and assume fingerprinting is more granular than your current consent banners admit.
Deep & Emerging TechPimco Says Junk Debt for Data Centers Diverging Into Two Markets
When Pimco says high-yield data center debt is splitting into winners and losers, the message is simple — not all “AI infra” paper is equal. If you’re financing or leasing capacity, underwrite power, utilization, and anchor tenants like you would a port or pipeline, not an office park.
Deep & Emerging TechQilimanjaro Inaugurates an Analog Quantum Computer at Barcelona Supercomputing Center
Analog quantum standing up inside MareNostrum 5 is a bet that hybrid HPC–quantum workflows move from theory to production in specific niches—optimization, simulation, cryptography. If you're running large-scale physics, materials, or logistics workloads in Europe, you now have a live testbed to start carving off quantum-suitable subproblems.